Switch to:
More From Other Websites
Amgen Inc Conference Call on Kyprolis at ESMO scheduled for 4:00 pm ET today Sep 29 2014
AMGN, ACT And GILD, Pushing Drugs Industry Downward Sep 29 2014
[video] Biotech selloff: What to buy Sep 25 2014
Biotech selloff: What to buy Sep 25 2014
Zacks Rank #1 Additions for Thursday Sep 25 2014
Amgen to Host Summary Webcast of Kyprolis® (carfilzomib) for Injection Data Presented at The... Sep 24 2014
Acorda To Buy Civitas, Gains Parkinson's Disease Drug Sep 24 2014
For Second Act, Acorda Drops $525 Million On Inhaled Parkinson's Drug Sep 24 2014
ESMO 2014 to Feature New Oncology Data from Across Bayer Franchise Sep 24 2014
Amgen Submits Biologics License Application for Investigational BiTE® Immunotherapy Blinatumomab Sep 22 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 19 2014
Today's Market Thorns, Roses and All Time Highs... Sep 18 2014
UCB-Amgen Reveals Positive Data on Romosozumab for PMO Sep 17 2014
The Market's Thorns, Roses, and All Time Highs... Sep 17 2014
Amgen, Inc. Poised To Break Higher Sep 17 2014
Biotech still place to be: Pro Sep 15 2014
[video] Biotech still place to be: Pro Sep 15 2014
Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of... Sep 15 2014
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued... Sep 15 2014
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure Sep 14 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK